Coxsackie virus A10 domestication strain containing virus composition and application of virus composition

A coxsackie virus and composition technology, applied in the biological field, can solve the problems of unstable passage, affecting the efficiency of virus strains, and titer reduction, so as to achieve the effect of preventing and/or treating diseases

Inactive Publication Date: 2018-02-27
SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI
View PDF5 Cites 7 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] There are many studies on Coxsackie virus, but there are few reports on the A10 virus strain
People such as Zhuang Zaicheng disclosed A10 virus strain M2014 in CN106661102A, but, this virus strain can only infect HEK293 cell, and can not infect other cell strains that are used for vaccine production, as, Vero cell, MRC-5 cell, MDCK cell As well as CHO cells, the highest virus titer can only reach 2.5×10 8 TCID 50 /mL, which largely limits the application of this virus strain
In our previous work, we screened the A10 virus strain TA151R, est

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Coxsackie virus A10 domestication strain containing virus composition and application of virus composition
  • Coxsackie virus A10 domestication strain containing virus composition and application of virus composition
  • Coxsackie virus A10 domestication strain containing virus composition and application of virus composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0054] Example 1 Isolation, Screening and Domestication of Coxsackievirus A10 Type Strain

[0055] The inventors carried out a lot of isolation and screening work in the early stage. In 2015, the Coxsackie virus A10 strain TA151R was isolated from the stool sample of a 4-year-old child in Shandong Province, and the infection was established using this strain. Animal model, prepared the whole virus inactivated vaccine, and studied the immune protection effect of the vaccine ("Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection", Zhenjie Zhang et al., "Journal of Virology", Volume 91, 2017, e00333-17). In the follow-up research process, we found that TA151R would have the problems of decreased titer and unstable passage during the passage process, which seriously restricted the application of this strain; in order to solve this problem, we carried out domestication screening for TA151R.

[0056] ...

Embodiment 2

[0059] Example 2 Passage stability of high titer domesticated strain XH01-08

[0060] RD cells were used to continuously subculture the high-titer domesticated strain XH01-08 in Example 1. When the cells showed a cytopathic effect area of ​​more than 80%, they were repeatedly frozen and thawed 3 times, and the first-generation virus liquid was collected and assayed. Virus titer: The harvested first-generation virus was continuously passaged 30 times in the same way, and the virus was collected and titered for each generation, and the virus titer of different generations was compared. Such as figure 1 As shown, XH01, XH02, XH05, XH06, and XH08 showed different titer reduction or titer instability during the subculture process, while XH03, XH04, and XH07 had better stability during the subculture process and could produce high titer of virus.

Embodiment 3

[0061] Example 3 Antiserum Test of Domesticated Strain XH03 / XH04 / XH07

[0062]0.4% formaldehyde-inactivated TA151R, XH03, XH04, and XH07 antigens were mixed with complete Freund's adjuvant and incomplete Freund's adjuvant in a volume ratio of 1:1, and after ultrasonic emulsification, 6-week-old ICR mice (n= 6) Inject complete Freund's adjuvant and antigen emulsion 300ul intraperitoneally, and after an interval of 7 days, inject incomplete Freund's adjuvant and antigen emulsion 300ul intraperitoneally, and take peripheral blood from the orbital venous plexus of immunized mice 20 days later and centrifuge serum. After 2-fold serial dilution of the immune serum starting from 1:8, they were mixed with 100CCID50 (Cell culture infective dose 50%) of CVA10 respectively, placed at 37°C for 2 hours, and the mixture was added to a 96-well plate of monolayer RD cells (1 ×10 5 / hole), put CO 2 Cultivate in an incubator at 37°C for 48 hours, observe the CPE of the cells, and take the r...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Titeraaaaaaaaaa
Login to view more

Abstract

The invention discloses a Coxsackie virus A10 domestication strain TA151R-1 with high titer and stable passage. The virus strain can infect various cell strains including RD cells, HEK 293 cells, Verocells, MRC-5 cells, Hep-2 cells, WI-38 cells and the like and can also be used for preparing a monovalent vaccine or a polyvalent vaccine; the prepared vaccine can protect an organism from damages from Coxsackie virus, can also completely prevent the attacks from other heterologous viruses, can effectively prevent and/or treat diseases caused by infection of the Coxsackie virus and has a wide application prospect.

Description

Technical field: [0001] The present application relates to the field of biotechnology, in particular to a virus composition comprising an acclimated strain of Coxsackievirus A10 and its application. Background technique: [0002] Hand, foot, and mouth disease (HFMD) is an intestinal infectious disease caused by a small RNA virus. The patients are mainly infants under 5 years old. It mainly causes mild clinical symptoms such as mucosal herpes and angina. Symptoms can also cause severe illness, leading to neurological diseases such as severe aseptic meningitis and acute flaccid paralysis. Since the epidemic in 2009, the incidence of Coxsackievirus A group 6 (A6) and 10 (A10) has increased year by year in the Western Pacific region and some countries in Europe, including Singapore, Thailand, Japan, Spain, France, Mainland China and Taiwan make it the main pathogen causing HFMD. As non-EV71 and non-A16, A6 and A10 are considered to be the main pathogens causing HFMD among othe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N7/00A61K39/295A61K39/125A61P31/14
CPCA61K39/12A61K2039/5252A61K2039/70C12N7/00C12N2770/32321C12N2770/32334
Inventor 史卫峰张振杰李娟董兆鹏
Owner SHANDONG FIRST MEDICAL UNIV & SHANDONG ACADEMY OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap